.png)
Manuel Trujillo, M.D.
Providing Quality Psychiatric Solutions
Biography
​
For the last 30 years, I have been ( and continue to be ) a Professor of Psychiatry at New York University Grossman Medical School ( ranked 6th among US Medical Schools ), where I was Director of Psychiatry of the legendary Bellevue Hospital, the oldest psychiatric Department in the Nation ( 1736) and the seat of many innovations in psychiatric care for centuries. At NYU- Bellevue Psychiatry, I was Director ( 1990 to 2008 ), and in 2008, I founded and directed a specialty training program for physicians ( Fellowship in Public Psychiatry ) were I now teach, and along the way many new programs in the academic and the private sector of Psychiatry. I am also deeply immersed in discovering applications of neuroimaging to the diagnosis and treatment of psychiatric disorders, a rather new area of psychiatric inquiry, which will pay great dividends in the immediate future as more psychiatrists become familiar with the growing uses of neuroimaging in psychiatry. Right now, fewer than 10% of patients presenting with a psychiatric disorder, undergo any neuroimaging study, including Electro Encephalogram ( EEG ), Q-EEG, MRI, fMRI, PET or SPECT.
​
Physicians in my group (founded by Dr. Daniel Amen from California) have obtained more than 200 thousand scans over the last 2-3 decades: a veritable treasure- trove for Artificial Intelligence, Machine Learning driven studies of effectiveness of care. We have initiated those studies, and will implement many more over the next few years. The next major challenge in psychiatric care is related to making care available to all, at reasonable costs and reasonable convenience; a challenge that can only be met through the extensive use of sophisticated technology that provides clinicians with automatic patient information (via sensors, automatic reading of voice and language inputs), miniaturized methods for brain waves acquisition (EEG Band aids) a clinical process that would permit the delivery of more precise medications and other therapies.
I am committed to contribute to the development of this future by continued participation in the development of clinical algorithms and best practices based on neuroimaging, and in the development of effective deep therapies which can be delivered through many means, in the spirit of my earlier research in trying to shorten and enhance the effect of therapies based on psychoanalytic principles.
​
​
-Manuel Trujillo M.D.
​
​
After medical school training in my native Spain (Seville), I came to the US in 1970 for psychiatric, psychoanalytic and psychiatric research training, and have devoted my career to three concurrent goals: 1) discovering new methods for the care of various specific psychiatric disorders, which were poorly understood (and or treated at) the time I graduated medical school.2) to develop new ways to deliver such care to more people , and to culturally diverse populations, as many psychiatric patients avoided, or were rejected by, conventional health systems and facilities, and thus met poorer outcomes. And 3) to develop methods or programs to teach physicians and other clinicians the principles underlying both activities.
